EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Pioglitazone Protects Tubular Epithelial Cells during Kidney Fibrosis by Attenuating miRNA Dysregulation and Autophagy Dysfunction Induced by TGF-β

Anna Manzéger, Gantsetseg Garmaa iD, Miklós M Mózes, Georg Hansmann iD, Gábor Kökény iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms242115520 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Anna Manzéger und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Translational Medicine, Semmelweis University, Nagyvárad tér 4, 1089 Budapest, Hungary. Hauptthemen laut MEDLINE: MicroRNAs, Kidney Diseases. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Stipendium Hungaricum Scholarship (Tempus Public Foundation, Hungary) and SE 250+ Excel-lence Ph.D. Scholarship (Semmelweis University), Bolyai Scholarship of the Hungarian Academy of Sciences, ÚNKP Bolyai+ Scholarship from the Hungarian Ministry of Innovation and Technology and the National Research, Development and Innovation Office.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Excessive renal TGF-β production and pro-fibrotic miRNAs are important drivers of kidney fibrosis that lack any efficient treatment. Dysfunctional autophagy might play an important role in the pathogenesis. We aimed to study the yet unknown effects of peroxisome proliferator-activated receptor-γ (PPARγ) agonist pioglitazone (Pio) on renal autophagy and miRNA dysregulation during fibrosis. Mouse primary tubular epithelial cells (PTEC) were isolated, pre-treated with 5 µM pioglitazone, and then stimulated with 10 ng/mL TGF-β1 for 24 h. Male 10-week-old C57Bl6 control (CTL) and TGF-β overexpressing mice were fed with regular chow (TGF) or Pio-containing chow (20 mg/kg/day) for 5 weeks (TGF + Pio). PTEC and kidneys were evaluated for mRNA and protein expression. In PTEC, pioglitazone attenuated (p < 0.05) the TGF-β-induced up-regulation of Col1a1 (1.4-fold), Tgfb1 (2.2-fold), Ctgf (1.5-fold), Egr2 (2.5-fold) mRNAs, miR-130a (1.6-fold), and miR-199a (1.5-fold), inhibited epithelial-to-mesenchymal transition, and rescued autophagy function. In TGF mice, pioglitazone greatly improved kidney fibrosis and related dysfunctional autophagy (increased LC3-II/I ratio and reduced SQSTM1 protein content (p < 0.05)). These were accompanied by 5-fold, 3-fold, 12-fold, and 2-fold suppression (p < 0.05) of renal Ccl2, Il6, C3, and Lgals3 mRNA expression, respectively. Our results implicate that pioglitazone counteracts multiple pro-fibrotic processes in the kidney, including autophagy dysfunction and miRNA dysregulation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsKidney DiseasesMaleMiceAnimalsPioglitazoneTransforming Growth Factor betaKidneyTransforming Growth Factor beta1RNA, MessengerFibrosisAutophagyEpithelial Cells

Stichwörter der Autor:innen

PPARγTGF-βautophagykidney fibrosismiRNAtranscription factors

Substanzen

PioglitazoneTransforming Growth Factor betaMicroRNAsTransforming Growth Factor beta1RNA, Messenger

Autor:innen und Institutionen

  • Institute of Translational Medicine, Semmelweis University, Nagyvárad tér 4, 1089 Budapest, Hungary.
  • International Nephrology Research and Training Center, Semmelweis University, Nagyvárad tér 4, 1089 Budapest, Hungary.
  • Department of Pediatric Cardiology and Critical Care, Hannover Medical School, 30625 Hannover, Germany.

ORCID-Profile: Gantsetseg Garmaa, Georg Hansmann, Gábor Kökény

Förderung

  • Stipendium Hungaricum Scholarship (Tempus Public Foundation, Hungary) and SE 250+ Excel-lence Ph.D. Scholarship (Semmelweis University)
  • Bolyai Scholarship of the Hungarian Academy of Sciences
  • ÚNKP Bolyai+ Scholarship from the Hungarian Ministry of Innovation and Technology and the National Research, Development and Innovation Office
  • Hungarian Society of Hypertension
  • Hungarian Society of Nephrology

Zitieren

APA

Manzéger, A., Garmaa, G., Mózes, M. M., Hansmann, G., & Kökény, G. (2023). Pioglitazone Protects Tubular Epithelial Cells during Kidney Fibrosis by Attenuating miRNA Dysregulation and Autophagy Dysfunction Induced by TGF-β. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms242115520

Vancouver

Manzéger A, Garmaa G, Mózes MM, Hansmann G, Kökény G. Pioglitazone Protects Tubular Epithelial Cells during Kidney Fibrosis by Attenuating miRNA Dysregulation and Autophagy Dysfunction Induced by TGF-β. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms242115520

BibTeX
@article{Manzger2023,
  author = {Manzéger, Anna and Garmaa, Gantsetseg and Mózes, Miklós M and Hansmann, Georg and Kökény, Gábor},
  title = {Pioglitazone Protects Tubular Epithelial Cells during Kidney Fibrosis by Attenuating miRNA Dysregulation and Autophagy Dysfunction Induced by TGF-β},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms242115520}
}
Kostenlos starten →